Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-028379
Filing Date
2025-05-29
Accepted
2025-05-29 16:46:56
Documents
1
Period of Report
2025-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748551609.html 4  
1 FORM 4 wk-form4_1748551609.xml 4 13666
  Complete submission text file 0001628280-25-028379.txt   15161
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Issuer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
SHAROKY MELVIN MD (Reporting) CIK: 0001182633 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30739 | Film No.: 251004236